Robinson BW - Search Results

1

Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.

Kirschner MB, Cheng YY, Badrian B, Kao SC, Creaney J, Edelman JJ, Armstrong NJ, Vallely MP, Musk AW, Robinson BW, McCaughan BC, Klebe S, Mutsaers SE, van Zandwijk N, Reid G. Kirschner MB, et al. Among authors: robinson bw. J Thorac Oncol. 2012 Jul;7(7):1184-91. doi: 10.1097/JTO.0b013e3182572e83. J Thorac Oncol. 2012. PMID: 22617246 Free article.

2

Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions.

Manning LS, Whitaker D, Murch AR, Garlepp MJ, Davis MR, Musk AW, Robinson BW. Manning LS, et al. Among authors: robinson bw. Int J Cancer. 1991 Jan 21;47(2):285-90. doi: 10.1002/ijc.2910470219. Int J Cancer. 1991. PMID: 1703129

3

Asbestos-induced release of a human alveolar macrophage-derived neutrophil chemotactic factor.

Hayes AA, Venaille TJ, Rose AH, Musk AW, Robinson BW. Hayes AA, et al. Among authors: robinson bw. Exp Lung Res. 1990 Mar-Apr;16(2):121-30. doi: 10.3109/01902149009087877. Exp Lung Res. 1990. PMID: 2184026 Free article.

4

Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma.

Manning LS, Bowman RV, Davis MR, Musk AW, Robinson BW. Manning LS, et al. Among authors: robinson bw. Clin Immunol Immunopathol. 1989 Oct;53(1):68-77. doi: 10.1016/0090-1229(89)90102-5. Clin Immunol Immunopathol. 1989. PMID: 2788546

5

Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals.

Hayes AA, Rose AH, Musk AW, Robinson BW. Hayes AA, et al. Among authors: robinson bw. Chest. 1988 Sep;94(3):521-5. doi: 10.1378/chest.94.3.521. Chest. 1988. PMID: 3044701

6

Increased pulmonary gamma interferon production in asbestosis.

Robinson BW, Rose AH, Hayes A, Musk AW. Robinson BW, et al. Am Rev Respir Dis. 1988 Aug;138(2):278-83. doi: 10.1164/ajrccm/138.2.278. Am Rev Respir Dis. 1988. PMID: 3143284

7

Bronchoalveolar lavage sampling of airway and alveolar cells.

Robinson BW, James A, Rose AH, Sterrett GF, Musk AW. Robinson BW, et al. Br J Dis Chest. 1988 Jan;82(1):45-55. doi: 10.1016/0007-0971(88)90007-1. Br J Dis Chest. 1988. PMID: 3166918

8

Benign asbestos pleural effusion: diagnosis and course.

Robinson BW, Musk AW. Robinson BW, et al. Thorax. 1981 Dec;36(12):896-900. doi: 10.1136/thx.36.12.896. Thorax. 1981. PMID: 7336367 Free PMC article.

9

Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.

Upham JW, Garlepp MJ, Musk AW, Robinson BW. Upham JW, et al. Among authors: robinson bw. Thorax. 1995 Aug;50(8):887-93. doi: 10.1136/thx.50.8.887. Thorax. 1995. PMID: 7570443 Free PMC article. Review. No abstract available.

10

Potential for interferon-alpha-based therapy in mesothelioma: assessment in a murine model.

Bielefeldt-Ohmann H, Fitzpatrick DR, Marzo AL, Jarnicki AG, Musk AW, Robinson BW. Bielefeldt-Ohmann H, et al. Among authors: robinson bw. J Interferon Cytokine Res. 1995 Mar;15(3):213-23. doi: 10.1089/jir.1995.15.213. J Interferon Cytokine Res. 1995. PMID: 7584666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters